AU7491396A - Infusions of neuroprotectants and thrombolytic agents - Google Patents
Infusions of neuroprotectants and thrombolytic agentsInfo
- Publication number
- AU7491396A AU7491396A AU74913/96A AU7491396A AU7491396A AU 7491396 A AU7491396 A AU 7491396A AU 74913/96 A AU74913/96 A AU 74913/96A AU 7491396 A AU7491396 A AU 7491396A AU 7491396 A AU7491396 A AU 7491396A
- Authority
- AU
- Australia
- Prior art keywords
- neuroprotectants
- infusions
- thrombolytic agents
- thrombolytic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95202887 | 1995-10-25 | ||
EP95202887 | 1995-10-25 | ||
EP96201642 | 1996-06-12 | ||
EP96201642 | 1996-06-12 | ||
PCT/EP1996/004609 WO1997015323A1 (en) | 1995-10-25 | 1996-10-21 | Infusions of neuroprotectants and thrombolytic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7491396A true AU7491396A (en) | 1997-05-15 |
Family
ID=26139737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU74913/96A Abandoned AU7491396A (en) | 1995-10-25 | 1996-10-21 | Infusions of neuroprotectants and thrombolytic agents |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0862457A1 (en) |
JP (1) | JPH11515010A (en) |
AU (1) | AU7491396A (en) |
WO (1) | WO1997015323A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007510756A (en) * | 2003-11-12 | 2007-04-26 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Compositions of cyclooxygenase-2 selective inhibitors and neurotrophic factor modulators for treating central nervous system mediated disorders |
JP2008230968A (en) * | 2005-06-30 | 2008-10-02 | Taisho Pharmaceutical Co Ltd | Pharmaceutical for use in the treatment of cerebral infarction |
WO2011013668A1 (en) * | 2009-07-27 | 2011-02-03 | 国立大学法人新潟大学 | Pharmaceutical composition for treatment of ischemic events |
US8652476B2 (en) | 2009-07-27 | 2014-02-18 | Niigata University | Pharmaceutical composition for treating ischemic events |
US10617756B2 (en) | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4129603A1 (en) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
GB9225141D0 (en) * | 1992-12-01 | 1993-01-20 | Smithkline Beecham Corp | Chemical compounds |
-
1996
- 1996-10-21 WO PCT/EP1996/004609 patent/WO1997015323A1/en not_active Application Discontinuation
- 1996-10-21 JP JP9516280A patent/JPH11515010A/en active Pending
- 1996-10-21 EP EP96937215A patent/EP0862457A1/en not_active Withdrawn
- 1996-10-21 AU AU74913/96A patent/AU7491396A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997015323A1 (en) | 1997-05-01 |
EP0862457A1 (en) | 1998-09-09 |
JPH11515010A (en) | 1999-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7435296A (en) | Novel expression vectors and methods of use | |
EP0863748A4 (en) | Liposomal compositions and methods of using them | |
AU5644896A (en) | Protease variants and compositions | |
AU7710198A (en) | Single pass lead and method of use | |
AU4896096A (en) | Optically active aminoindane derivatives and preparation thereof | |
AU1372897A (en) | 2-amino-heterocycles and therapeutic uses therefor | |
AU4266596A (en) | Composition and use | |
AU5040896A (en) | Benzonitriles and benzofluorides | |
AU6120994A (en) | Anticonvulsive agents and uses thereof | |
NZ300198A (en) | Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines | |
AU7621496A (en) | Microsensor and use of such microsensor | |
AU7290898A (en) | Preparation of fagopyritols and uses therefor | |
AU4224096A (en) | Use of phenylcyclohexylcarboxamides | |
AU3118297A (en) | Sok-1 and methods of use | |
AU7491396A (en) | Infusions of neuroprotectants and thrombolytic agents | |
AU7529796A (en) | S-nitroso-hemoglobin and therapeutic uses thereof | |
AU2512495A (en) | Therapeutic phenoxyalkylazoles and phenoxyalkylazines | |
AU7139996A (en) | Mercaptoamide derivatives and their therapeutic use | |
AU6975996A (en) | Stabilized agchemical concentrate and use thereof | |
ZA968952B (en) | Infusions of neuroprotectants and thrombolytic agents. | |
AU5188296A (en) | Carbopeptoids and carbonucleotoids | |
AU8750198A (en) | Antibiotic preparations and use of the same | |
AU7298196A (en) | Infusions of neuroprotectants and perfluorochemicals | |
AU5697996A (en) | Peptidyl compounds and their therapeutic use | |
AU7669796A (en) | Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides |